IMMUNE ONCIA THERAPEUTICS INC.

Serial Number 79418671
661

Registration Progress

Application Filed
Dec 31, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

IMMUNE ONCIA THERAPEUTICS INC.

Basic Information

Serial Number
79418671
Filing Date
December 31, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
661
Status Date
Dec 12, 2025
Application
Pending
Classes
005

Rights Holder

ImmuneOncia Therapeutics, Inc.

03
Address
25, Tapsil-ro, 35 beon-gil, Giheung-gu
Yongin-si, Gyeonggi-do
KR

Ownership History

ImmuneOncia Therapeutics, Inc.

Original Applicant
03
KR

Legal Representation

Attorney
Dmitriy O. Makarov

Application History

14 events
Date Code Type Description Documents
Dec 12, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 11, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 11, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 10, 2025 CORN I CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Aug 23, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Aug 7, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 6, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jun 18, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jun 17, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 12, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 12, 2025 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Mar 14, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 14, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 6, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumours; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; anti-cancer preparations; tumor suppressing agents; medical and surgical plasters; adhesive plasters for medical purposes

Additional Information

Design Mark
The mark consists of the stylized wording "IMMUNEONCIA THERAPEUTICS INC." with "IMMUNE" and "IA " in black, "ONC in blue and "THERAPEUTICS INC." in gray and a design of various circles in blue and sky-blue with one circle connecting to the "O" forming an amoeba-like shape.
Translation
The English translation of "ONCIA" in the mark is "ounce" in Italian. However, when selecting the mark, the Applicant did not contemplate ONCIA's Italian meaning.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS INC."